Ascendis Pharma A/s
(NASDAQ) ASND
Ascendis Pharma A/s Financials at a Glance
Market Cap
$13.53B
Revenue (TTM)
$717.81M
Net Income (TTM)
$227.72M
EPS (TTM)
$-4.20
P/E Ratio
-52.53
Dividend
$0.00
Beta (Volatility)
0.71 (Low)
Dividend
$0.00
Beta (Volatility)
0.71 (Low)
Price
$233.36
Volume
617,405.807
Open
$221.20
Price
$233.36
Volume
617,405.807
Open
$221.20
Previous Close
$220.48
Daily Range
$216.53 - $232.78
52-Week Range
$124.06 - $248.60
Dividend
$0.00
Beta (Volatility)
0.71 (Low)
Price
$233.36
Volume
617,405.807
Open
$221.20
Previous Close
$220.48
Daily Range
$216.53 - $232.78
52-Week Range
$124.06 - $248.60
ASND News
ASND: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ascendis Pharma A/s
Industry
Biotechnology
Sector
Health CareCEO
Jan Møller Mikkelsen
Website
www.ascendispharma.comHeadquarters
Hellerup, 2900, DK
ASND Financials
Key Financial Metrics (TTM)
Gross Margin
86%
Operating Margin
-19%
Net Income Margin
-32%
Return on Equity
0%
Return on Capital
-59%
Return on Assets
-17%
Earnings Yield
-1.90%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$13.53B
Shares Outstanding
61.38M
Volume
617.41K
Short Interest
0.00%
Avg. Volume
677.41K
Financials (TTM)
Gross Profit
$588.53M
Operating Income
$130.89M
EBITDA
$113.90M
Operating Cash Flow
$51.77M
Capital Expenditure
$8.15M
Free Cash Flow
$43.62M
Cash & ST Invst.
$615.78M
Total Debt
$871.41M
Ascendis Pharma A/s Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$245.18M
+41.0%
Gross Profit
$217.98M
+36.3%
Gross Margin
88.91%
N/A
Market Cap
$13.53B
N/A
Market Cap/Employee
$13.31M
N/A
Employees
1,017
N/A
Net Income
$33.25M
+13.6%
EBITDA
$14.58M
+138.5%
Quarterly Fundamentals
Net Cash
$255.64M
+13.9%
Accounts Receivable
$157.63M
-5.2%
Inventory
$301.40M
+2.0%
Long Term Debt
$385.09M
+5.5%
Short Term Debt
$486.32M
-1.1%
Return on Assets
-17.49%
N/A
Return on Invested Capital
-58.50%
N/A
Free Cash Flow
$67.37M
+176.9%
Operating Cash Flow
$70.67M
+181.1%